Features of the Circulation of ARVI Pathogens During of Emergence and Widespread of SARS-CoV-2 in the 2018

Features of the Circulation of ARVI Pathogens During of Emergence and Widespread of SARS-CoV-2 in the 2018–2021

Published:2022-09-13 Issue:4 Volume:21 Page:16-26
ISSN:2619-0494
Container-title:Epidemiology and Vaccinal Prevention
language:
Short-container-title:Epidemiology and Vaccinal Prevention

Author:

Burtseva E. I.¹^ORCID,Kolobukhina L. V.¹^ORCID,Voronina O. L.¹^ORCID,Ignatjeva A. V.¹^ORCID,Mukasheva E. A.¹^ORCID,Panova A. D.¹^ORCID,Feodoritova E. L.¹^ORCID,Krasnoslodotsev K. G.¹^ORCID,Trushakova S. V.¹^ORCID,Merkulova L. N.¹^ORCID,Khlopova I. N.¹^ORCID,Breslav N. V.¹^ORCID,Ryzhova N. N.¹^ORCID,Kunda M. S.¹^ORCID,Aksenova E. I.¹^ORCID,Vartanyan R. V.¹^ORCID,Kisteneva L. B.¹^ORCID,Burgasova O. A.¹^ORCID,Rosatkevich A. G.¹^ORCID,Kruzhkova I. S.¹^ORCID,Bazarova M. V.²^ORCID,Smetanina S. V.²^ORCID,Tsvetkova N. A.³^ORCID,Levochkina Yu. S.⁴^ORCID,Kozlova M. V.³^ORCID,Korostin D. O.⁵^ORCID,Botsmanov E. I.⁵^ORCID

Affiliation:

1. FSBI National Research Centre of Epidemiology and Microbiology named after honorary academician N.F. Gamaleya of Ministry of Health

2. Clinical Hospital for Infectious Diseases № 1 Department of Health of Moscow

3. Clinical Hospital for Infectious Diseases № 2 Department of Health of Moscow

4. FSBI National Research Centre of Epidemiology and Microbiology named after honorary academician N.F. Gamaleya of Ministry of Health; Clinical Hospital for Infectious Diseases № 2 Department of Health of Moscow

5. Center for High-Precision Editing and Genetic Technologies for Biomedicine of the N.I. Pirogov Federal State Medical University of the Ministry of Health of Russia

Abstract

Relevance. The long-term leadership of ARVI pathogens determines their significance in the damage caused to both health and the economy of the country. Aim. To identify the features of the structure of ARVI during the emergence and widespread spread of SARS-CoV-2. Materials and methods. The article uses methods used in epidemiological surveillance of acute respiratory viral infections. Results and discussion. The results of the diagnostic available ARVI pathogens monitoring during epidemic seasons 2018-2021 are presented. The tendency of greater engagement of aged group 15 y.o. and older in epidemic process by morbidity and hospitalization due to SARI was shown. 49 818 nasal swabs from patients with influenza infection, 36 044 – with ARVI and 59 062 – with SARS-CoV-2 were tested. The top three in the structure of ARVI were INF, HEV-D and HRSV (in the 2018–2019 season); INF, SARS-CoV-2 and HEV-D (2019–2020); SARS-CoV-2, HEV-D and HPIV/HCoV (2020–2021). The activity of viral pathogens also differed: for HPIV, HAdV, HEV-D, HMPV, a decrease in activity was noted during the appearance of SARS-CoV-2 (2019–2020) and some of its growth in the following season; in relation to HRSV and INF - a decrease in activity during the last two seasons, and for INF – extremely low activity in the 2020-2021 season; the activity of seasonal HCoV even increased slightly. The data of genetic analyses of SARS-CoV-2 positive samples showed the heterogeneity of its population with a representative of variants (Alfa, Delta) as well as endemic for Russia and Moscow variants only. The recommended composition of influenza virus vaccines for use in the 2021–2022 northern hemisphere influenza season and in the 2022 southern hemisphere influenza season are presented due to their drift changeability. Conclusions. SARS-CoV-2 was influenced by the activity of ARVI pathogens with the almost complete displacement of influenza viruses from the circulation in the period 2020–2021.

Publisher

LLC Numicom

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,Epidemiology

Reference25 articles.

1. On the state of sanitary and epidemiological welfare of the population in the Russian Federation in 2020: State Report. Moscow: Federal Service for Supervision of Consumer Rights Protection and Human Well-being. 2021:256 (in Russ.).

2. Ljublin-Sternak S., Mestrovich T., Luksic I., et al. Seasonal Coronaviruses and other neglected respiratory viruses: a global perspective and a local snapshot Front. Public Health. 2021;(9):691163.

3. Lvоv D.K., Burtseva E.I., Kolobukhina L.V., et al. Features of the circulation of influenza and SARS viruses in the epidemic season 2019-2020 in certain regions of Russia Questions of virology, 2020;N.6:335–349 (in Russ.).

4. Lvov D.K., Gulyukin M.I., Zaberezhny A.D., et al. Formation of a population gene pool potentially threatening the biosafety of zoonotic viruses Questions of virology. 2020;65(5):243–258 (in Russ.).

5. WHO Director-General’s opening remarks at the media briefing on COVID-19, 11 March 2020. Available at: https:www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19–11-march-2020.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Etiologic Characteristics of Influenza Epidemics on the Territory of Russia in the Period of Pandemic COVID-19 in 2020–2023;Epidemiology and Vaccinal Prevention;2024-07-10

2. Combined course of severe whooping cough with rhinovirus infection and COVID-19 in an early child;CHILDREN INFECTIONS;2024-06-24

3. Metapneumovirus infection in children in modern conditions: clinical and immunological parallels;CHILDREN INFECTIONS;2024-03-22

4. Properties of influenza viruses that caused epidemic increases in morbidity in Russia and countries of the world during 2022–2023. The effectiveness of vaccine prophylaxis;Problems of Virology;2024-03-14

5. Flu yesterday, today and tomorrow. The results of monitoring immunization and morbidity in the epidemic seasons 2019–2020, 2020–2021, 2021–2022, 2022–2023;Epidemiology and Infectious Diseases;2024-01-30